Astrazeneca Receives Japan Approval For CFC-free Corticosteroid Inhaler For Paediatric Asthma

... Astrazeneca announced on July 27 that it had received approval for its Pulmicort Turbuhaler, an inhaler for pediatric asthma infants from 6 months to under 5 years old, frrom the Japanese Ministry of Health, Labor and Welfare. Pulmicort Turbuhaler is taken once daily with an electronic nebuliser that change liquid medicines into a fine mist for easy breathing in. [click link for full article] ...